Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome

Abstract We aimed to evaluate the effect of baseline low-density lipoprotein cholesterol (LDL-C) on the outcomes of patients with the acute coronary syndrome (ACS) receiving pitavastatin monotherapy or the combination of pitavastatin + ezetimibe. In the HIJ-PROPER study, 1734 ACS patients with dysli...

Full description

Bibliographic Details
Main Authors: Jihaeng Im, Erisa Kawada-Watanabe, Junichi Yamaguchi, Hiroyuki Arashi, Hisao Otsuki, Yuko Matsui, Haruki Sekiguchi, Shinya Fujii, Fumiaki Mori, Hiroshi Ogawa, Nobuhisa Hagiwara
Format: Article
Language:English
Published: Nature Publishing Group 2021-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-87098-x

Internet

https://doi.org/10.1038/s41598-021-87098-x

Similar Items